EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical application of amplification-based versus amplification-free metagenomic next-generation sequencing test in infectious diseases

Zhe-Ying Wang, Lu-Lu Li, Xue-Lei Cao, Ping Li, Jian Du, Ming-Jin Zou, Li-Li Wang

Frontiers in Cellular and Infection Microbiology · 2023

DOI: 10.3389/fcimb.2023.1138174 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2023. Verfasst von Zhe-Ying Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Qilu Hospital of Shandong University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Communicable Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Recently, metagenomic next-generation sequencing (mNGS) has been used in the diagnosis of infectious diseases (IDs) as an emerging and powerful tool. However, whether the complicated methodological variation in mNGS detections makes a difference in their clinical performance is still unknown. Here we conducted a method study on the clinical application of mNGS tests in the DNA detection of IDs.

Methods

We analyzed the effect of several potential factors in the whole process of mNGS for DNA detection on microorganism identification in 98 samples of suspected ID patients by amplification-based mNGS. The amplification-based and amplification-free mNGS tests were successfully performed in 41 samples. Then we compared the clinical application of the two mNGS methods in the DNA detection of IDs.

Results

We found that a higher concentration of extracted nucleic acid was more conducive to detecting microorganisms. Other potential factors, such as read depth and proportion of human reads, might not be attributed to microorganism identification. The concordance rate of amplification-based and amplification-free mNGS results was 80.5% (33/41) in the patients with suspected IDs. Amplification-based mNGS showed approximately 16.7% higher sensitivity than amplification-free mNGS. However, 4 cases with causative pathogens only detected by amplification-based mNGS were finally proved false-positive. In addition, empirical antibiotic treatments were adjusted in 18 patients following mNGS testing with unexpected pathogens.

Conclusions

Amplification-based and amplification-free mNGS tests showed their specific advantages and disadvantages in the diagnosis of IDs. The clinical application of mNGS still needs more exploration from a methodological perspective. With advanced technology and standardized procedure, mNGS will play a promising role in the diagnosis of IDs and help guide the use of antibiotics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Communicable DiseasesHumansHigh-Throughput Nucleotide SequencingAnti-Bacterial AgentsMetagenomeMetagenomicsDNASensitivity and Specificity

Stichwörter der Autor:innen

PCR biasamplification-free methodinfectious diseasesmetagenomic next-generation sequencingmethodology

Substanzen

Anti-Bacterial AgentsDNA

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Qilu Hospital of Shandong University, Jinan, Shandong, China.
  • Shandong Engineering Research Center of Biomarker and Artificial Intelligence Application, Jinan, Shandong, China.
  • Department of Urology, The First Affiliated Hospital of Shandong First Medical University, Jinan, Shandong, China.

Zitieren

APA

Wang, Z. Y., Li, L. L., Cao, X. L., Li, P., Du, J., Zou, M. J., & Wang, L. L. (2023). Clinical application of amplification-based versus amplification-free metagenomic next-generation sequencing test in infectious diseases. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2023.1138174

Vancouver

Wang ZY, Li LL, Cao XL, Li P, Du J, Zou MJ, et al. Clinical application of amplification-based versus amplification-free metagenomic next-generation sequencing test in infectious diseases. Frontiers in Cellular and Infection Microbiology. 2023. doi:10.3389/fcimb.2023.1138174

BibTeX
@article{Wang2023,
  author = {Wang, Zhe-Ying and Li, Lu-Lu and Cao, Xue-Lei and Li, Ping and Du, Jian and Zou, Ming-Jin and Wang, Li-Li},
  title = {Clinical application of amplification-based versus amplification-free metagenomic next-generation sequencing test in infectious diseases},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2023},
  doi = {10.3389/fcimb.2023.1138174}
}
Kostenlos starten →